Business Description
This fund puts the vast majority of its money into healthcare companies from both the United States and abroad, focusing on businesses driving meaningful change in the industry. Areas of particular interest include gene science, personalized treatments, technology-assisted medical procedures, and digital health services. The fund takes a concentrated approach, meaning it holds fewer positions than a typical investment fund.
